Switzerland
Gilead Sciences Switzerland Sàrl
General-Guisan-Strasse 8
6300 Zug
Switzerland
Phone: 41 (0)41 580 02 00 41 (0)41 580 02 00
Fax: 41 (0)41 580 02 98
Gilead Sciences is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.
Gilead’s office in Zug is responsible for medical, sales and marketing activities for our products in Switzerland.
Relationships with Patient Organizations and NGOs
ilead provided support to the following patient organizations and NGOs in 2021. The information is correct at the time of writing (May 2022). The information is subject to change and periodic updates. For a listing of previous years’ payments, click here.
Gilead Sciences EFPIA Patient Organisations Support 2021 - Switzerland
Publication of Clinical Study Results
As of 2020, Gilead discloses clinical study results of newly authorized products in Switzerland by Swissmedic according to the requirements laid out in Art. 71-73 TPO (Ordinance on Therapeutic Products).
Products are listed in alphabetical order.
|
Product |
Active Substance |
Authorization Number |
Date of Authorization |
|---|---|---|---|
|
Autologous anti-CD19-transduced |
67884 |
25.08.2021 |
|
|
Sacituzumab govitecan |
68179 |
09.09.2021 |
|
|
Remdesivir |
68026 / 68043 |
25.11.2020 |
This page is intended for visitors outside of the United States.